Cannabis Bioscience International Holdings, Inc.
CBIH
$0.0008
$0.000114.29%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 56.02% | 40.22% | -23.23% | -37.47% | -29.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.02% | 40.22% | -23.23% | -37.47% | -29.44% |
| Cost of Revenue | -40.78% | -19.29% | -43.28% | -35.05% | 1.75% |
| Gross Profit | 92.42% | 57.26% | -16.54% | -38.12% | -36.73% |
| SG&A Expenses | -32.65% | -38.10% | -43.65% | -27.24% | -12.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.14% | -37.21% | -43.63% | -27.73% | -12.15% |
| Operating Income | 58.27% | 58.52% | 50.72% | 24.08% | 5.63% |
| Income Before Tax | 44.77% | 45.55% | 33.74% | 17.73% | -1.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.77% | 45.55% | 33.74% | 17.73% | -1.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.77% | 45.55% | 33.74% | 17.73% | -1.08% |
| EBIT | 58.27% | 58.52% | 50.72% | 24.08% | 5.63% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 8.58% | 14.86% | 20.42% | 23.01% | 15.17% |
| Average Diluted Shares Outstanding | 8.58% | 14.86% | 20.42% | 23.01% | 15.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
